In the multivariate analysis, the date showed that for each 1 ng/ml increase of FABP4, the association between FABP4 and stroke recurrence was stronger among patients who defined as obese (OR= 1.14, 95%CI: 1.09-1.22; P<0.001) versus non-obese (OR=1.06, 95%CI: 1.02-1.14; P=0.016). This evidence concerns the gene FABP4 and Stroke.